Breaking News Instant updates and real-time market news.

EL

Estee Lauder

$88.56

1.69 (1.95%)

, AVP

Avon Products

$5.66

0.14 (2.54%)

07:57
10/03/16
10/03
07:57
10/03/16
07:57

Chinese tax changes modestly positive for cosmetics makers, says Piper Jaffray

Piper Jaffray analyst Stephanie Wissink noted that the Chinese Ministry of Finance has reduced or eliminated the consumption tax on all cosmetic products as of October 1 to stimulate demand and growth, which she views as a modest positive for Estee Lauder (EL), Avon Products (AVP) and Coty (COTY). Of the three, Estee Lauder has the highest exposure to China, which makes up about 10% of its annual revenues, Wissink added.

EL

Estee Lauder

$88.56

1.69 (1.95%)

AVP

Avon Products

$5.66

0.14 (2.54%)

COTY

Coty

$23.50

0.42 (1.82%)

EL Estee Lauder
$88.56

1.69 (1.95%)

08/22/16
RBCM
08/22/16
NO CHANGE
RBCM
Estee Lauder should be bought on weakness, says RBC Capital
After Estee Lauder provided lower than expected fiscal 2017 EPS guidance and the stock fell 3.5% on Friday, RBC Capital analyst Nik Modi recommends that investors buy the shares on weakness. The analyst says that the company's lower than expected EPS and its "slightly disappointing" longer term margin guidance caused the stock to decline. However, he says that the company's revenue and EPS growth is outpacing peers, while its margin guidance is conservative and the stock is "cheap." He keeps a $107 price target and Outperform rating on the shares.
09/09/16
09/09/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JPMorgan (JPM) downgraded to Neutral from Outperform at Macquarie with analyst David Konrad citing valuation. 2. CarMax (KMX) downgraded to Neutral from Buy at Buckingham with analyst Glenn Chin citing valuation. 3. Eaton (ETN) and Ingersoll-Rand (IR) downgraded to Sector Weight from Overweight at KeyBanc with analyst Jeffrey Hammond citing his more cautious outlook for nonresidential construction. 4. Estee Lauder (EL) downgraded to Hold from Buy at Argus with analyst John Staszak saying it will be difficult for the company to achieve further market share gains, given increased competition, slowing growth in the premium beauty products space, and a "challenging" macro environment. 5. SAIC (SAIC) downgraded to Market Perform from Outperform at Cowen and to Hold from Buy at Drexel Hamilton. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/09/16
ARGS
09/09/16
DOWNGRADE
ARGS
Hold
Estee Lauder downgraded on weaker outlook at Argus
As noted earlier, Argus downgraded Estee Lauder to Hold from Buy. Analyst John Staszak says that it will be difficult for the company to achieve further market share gains, given increased competition, slowing growth in the premium beauty products space, and a "challenging" macro environment.
09/09/16
ARGS
09/09/16
DOWNGRADE
ARGS
Hold
Estee Lauder downgraded to Hold from Buy at Argus
AVP Avon Products
$5.66

0.14 (2.54%)

08/03/16
DBAB
08/03/16
NO CHANGE
Target $8
DBAB
Buy
Avon shares could double over next two years, says Deutsche Bank
Deutsche Bank analyst Bill Schmitz raised his price target for Avon Products to $8 from $7 following the company's Q2 results. The path to double digit margins, low to mid single digit organic growth and cash flow recovery is clearer with emerging markets stabilizing, Schmitz tells investors in a post-earnings research note. With consensus estimates no longer going down, the analyst says Avon is the only stock he covers that could double over the next two years. He keeps a Buy rating on the shares. Avon closed yesterday up 60c, or 14%, to $4.76.
06/03/16
06/03/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with a Buy at Sterne Agee CRT with analyst Rob Cihra arguing that while the electric carmaker is "controversial, expensive and risky," its growth is "open-ended" as it targets the trillion dollar auto and energy markets. Chira has a $300 price target on the stock. 2. Big Lots (BIG) initiated with an Outperform at Oppenheimer with analyst Brian Nagel citing ongoing turnaround potential. 3. GrubHub (GRUB) initiated with a Buy at Maxim. 4. Yelp (YELP) initiated with a Buy at Maxim. 5. Avon Products (AVP) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/03/16
JEFF
06/03/16
INITIATION
Target $41
JEFF
Hold
Nu Skin initiated with a Hold at Jefferies
Jefferies analyst Trevor Young started Nu Skin Enterprises (NUS) with a Hold rating and $41 price target. The analyst prefers the sidelines given the company's "narrow" product offering, high China exposure and guidance volatility. Young this morning also started Avon Products (AVP) with a Buy rating and $7 price target.
06/03/16
JEFF
06/03/16
INITIATION
Target $7
JEFF
Buy
Avon Products initiated with a Buy at Jefferies
Jefferies analyst Trevor Young started Avon Products with a Buy rating and $7 price target. Avon is in the early stages of its three-year transformation and selling the North American business to Cerberus alleviates cash worries, Young tells investors in a research note. He believes the company's remaining international business is poised for greater growth.
COTY Coty
$23.50

0.42 (1.82%)

09/29/16
RILY
09/29/16
UPGRADE
Target $23.25
RILY
Neutral
Coty upgraded to Neutral from Sell at B. Riley
B. Riley analyst Linda Bolton Weiser upgraded Coty to Neutral and raised her price target for the shares to $23.25 from $21.50. The stock is closer to fair value following the 20% pullback, Weiser tells investors in a research note.
04/18/16
BOFA
04/18/16
DOWNGRADE
BOFA
Neutral
Coty downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill downgraded Coty to Neutral citing recent share strength.
05/31/16
DBAB
05/31/16
NO CHANGE
Target $32
DBAB
Buy
Deutsche sees 'considerable value creation opportunities' for Coty
Deutsche Bank analyst Bill Schmitz believes "tepid" organic growth and deal integration challenges are dominating the Coty investor conversation into the P&G beauty asset close. The analyst, however, sees "considerable value creation opportunities" as Coty rationalizes the portfolio and supply chain, eliminates overhead and reinvests behind focus brands. He raised his price target for the shares to $32 from $31 and keeps a Buy rating on the name.
10/03/16
BOFA
10/03/16
UPGRADE
Target $28
BOFA
Buy
Coty upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Olivia Tong upgraded Coty to Buy with a $28 price target citing valuation. The analyst believes Coty is at the beginning of a potential transformation with the pending closure of the P&G Beauty deal this week that could bring increased scale as well as a more targeted operational structure.

TODAY'S FREE FLY STORIES

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

, ESALY

Eisai

$57.91

0.59 (1.03%)

04:55
12/03/16
12/03
04:55
12/03/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

ESALY

Eisai

$57.91

0.59 (1.03%)

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

IART

Integra LifeSciences

$75.78

-1.07 (-1.39%)

MDT

Medtronic

$72.01

0.13 (0.18%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

NVTA

Invitae

$6.95

0.16 (2.36%)

SAGE

SAGE Therapeutics

$49.02

-0.23 (-0.47%)

WTKWY

Wolters Kluwer

$34.08

-0.39 (-1.13%)

ZGNX

Zogenix

$13.05

0.35 (2.76%)

ZYNE

Zynerba

$13.64

0.83 (6.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

WMT

Wal-Mart

$70.88

0.21 (0.30%)

18:17
12/02/16
12/02
18:17
12/02/16
18:17
Periodicals
Wal-Mart to pay $7.5M to settle same-sex spouse benefit case, Reuters reports »

Wal-Mart said it would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

18:14
12/02/16
12/02
18:14
12/02/16
18:14
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

, ALIOF

Actelion

$206.01

15.21 (7.97%)

18:11
12/02/16
12/02
18:11
12/02/16
18:11
Periodicals
Johnson & Johnson said to raise offer for Actelion above $250, Bloomberg says »

Johnson &…

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

ALIOF

Actelion

$206.01

15.21 (7.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$79.10

0.3 (0.38%)

18:00
12/02/16
12/02
18:00
12/02/16
18:00
Hot Stocks
Celanese to raise list, off-list selling prices for paraformaldehyde »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, GMED

Globus Medical

$21.89

0.12 (0.55%)

17:56
12/02/16
12/02
17:56
12/02/16
17:56
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: HomeStreet…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

GMED

Globus Medical

$21.89

0.12 (0.55%)

BGS

B&G Foods

$42.50

0.2 (0.47%)

ZEN

Zendesk

$21.17

0.34 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Jan

ZEN

Zendesk

$21.17

0.34 (1.63%)

17:53
12/02/16
12/02
17:53
12/02/16
17:53
Hot Stocks
Zendesk says SVPs Amanda Kleha and Marcus Bragg to resign »

On November 29, Amanda…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:42
12/02/16
12/02
17:42
12/02/16
17:42
Periodicals
President Obama blocks China's Fujian from acquiring Aixtron, CNBC reports »

President Barack Obama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$7.83

0.09 (1.16%)

17:31
12/02/16
12/02
17:31
12/02/16
17:31
Hot Stocks
CEMEX to divest ready-mix concrete pumping assets in Mexico »

CEMEX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$5.15

-0.1 (-1.90%)

17:30
12/02/16
12/02
17:30
12/02/16
17:30
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MBRX

Moleculin Biotech

$2.63

-0.14 (-5.05%)

17:29
12/02/16
12/02
17:29
12/02/16
17:29
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NEOG

Neogen

$61.59

-1.46 (-2.32%)

17:28
12/02/16
12/02
17:28
12/02/16
17:28
Hot Stocks
Neogen acquires U.K.-based Quat-Chem, terms undisclosed »

Neogen announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRC

Range Resources

$36.36

-0.23 (-0.63%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Hot Stocks
Breaking Hot Stocks news story on Range Resources »

SailingStone Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$103.74

-1.01 (-0.96%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

17:22
12/02/16
12/02
17:22
12/02/16
17:22
Hot Stocks
Breaking Hot Stocks news story on HomeStreet, UMB Financial »

HomeStreet to replace UMB…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

, IM

Ingram Micro

$38.88

1.31 (3.49%)

17:21
12/02/16
12/02
17:21
12/02/16
17:21
Hot Stocks
UMB Financial to replace Ingram Micro in S&P 400 as of 12/6 close »

Tianjin Tianhai…

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

17:20
12/02/16
12/02
17:20
12/02/16
17:20
Hot Stocks
Globus Medical to replace Talen Energy in S&P 400 as of 12/6 close »

Riverstone Holdings is…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:16
12/02/16
12/02
17:16
12/02/16
17:16
Periodicals
President Obama blocks China's takeover of Aixtron, CNBC reports »

Says the transaction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$15.74

-0.32 (-1.99%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Periodicals
Deutsche Bank to pay $60M settlement over gold price-fixing case, Reuters says »

Deutsche Bank will pay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

ALB

Albemarle

$84.86

-0.79 (-0.92%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Hot Stocks
Albemarle to increase prices for select brominated products »

Albemarle announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

FOR

Forestar Group

$13.40

0.2 (1.52%)

17:06
12/02/16
12/02
17:06
12/02/16
17:06
Hot Stocks
Breaking Hot Stocks news story on Forestar Group »

Carlson Capital lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.